Tokyo, Japan

Makiko Tsuji

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Makiko Tsuji: Innovator in Mesothelioma Detection and Treatment

Introduction

Makiko Tsuji is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of mesothelioma. Her innovative work has the potential to improve patient outcomes and advance the understanding of this challenging disease.

Latest Patents

Makiko Tsuji holds a patent for an antibody that binds to HEG1, which is crucial for the detection and treatment of mesothelioma. The patent describes an antibody with high specificity and sensitivity to mesothelioma, providing a method for diagnosis using this antibody. Additionally, it includes a reagent and a kit for diagnosing mesothelioma, as well as a pharmaceutical composition for treatment. This invention represents a significant advancement in the fight against mesothelioma.

Career Highlights

Throughout her career, Makiko Tsuji has worked with esteemed institutions such as the Kanagawa Prefectural Hospital Organization and the University of Tokyo. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Makiko has collaborated with notable colleagues, including Shoutaro Tsuji and Taihei Kageyama. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in medical diagnostics.

Conclusion

Makiko Tsuji's work in developing an antibody for mesothelioma detection and treatment showcases her dedication to advancing medical science. Her contributions are vital in improving diagnostic methods and treatment options for patients suffering from this disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…